3,5-diiodothyropropionic acid and 3,5-diiodothyronine, (l)-isomer

3,5-diiodothyropropionic acid has been researched along with 3,5-diiodothyronine, (l)-isomer in 1 studies

Compound Research Comparison

Studies (3,5-diiodothyropropionic acid)	Trials (3,5-diiodothyropropionic acid)	Recent Studies (post-2010) (3,5-diiodothyropropionic acid)	Studies (3,5-diiodothyronine, (l)-isomer)	Trials (3,5-diiodothyronine, (l)-isomer)	Recent Studies (post-2010) (3,5-diiodothyronine, (l)-isomer)
47	4	12	7	0	4

Protein Interaction Comparison

Protein	Taxonomy	3,5-diiodothyropropionic acid (IC50)	3,5-diiodothyronine, (l)-isomer (IC50)
Proliferating cell nuclear antigen	Homo sapiens (human)		6.3

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Actis, M; Evison, B; Fujii, N; Inoue, A; Perry, S; Punchihewa, C	1

Other Studies

1 other study(ies) available for 3,5-diiodothyropropionic acid and 3,5-diiodothyronine, (l)-isomer

Article	Year
Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis. Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7 Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA; DNA Damage; DNA Replication; HeLa Cells; Humans; Neoplasms; Proliferating Cell Nuclear Antigen; Protein Interaction Maps; Small Molecule Libraries; Structure-Activity Relationship	2013

Article

Year

Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.

Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7

Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA; DNA Damage; DNA Replication; HeLa Cells; Humans; Neoplasms; Proliferating Cell Nuclear Antigen; Protein Interaction Maps; Small Molecule Libraries; Structure-Activity Relationship

2013